W. Scott Campbell, MBA, PhD James R. Campbell, MD

Slides:



Advertisements
Similar presentations
The Impact of Gynecologic Pathology Diagnostic Errors on Patient Care Dana Marie Grzybicki MD, PhD Colleen M. Vrbin, BA Danielle Pirain, BS Stephen S.
Advertisements

Surgical Pathology of Wide Local Excision of Breast
Histopathology and Cytology for Breast lesions Britt-Marie Ljung MD Professor of Pathology, Dir. of Cytology University of California at San Francisco.
Catalina Martínez-Costa, Stefan Schulz: Ontology-based reinterpretation of the SNOMED CT context model Ontology-based reinterpretation of the SNOMED CT.
Malignant Adenomyoepithelioma of the Breast with Lymph Node Metastasis
Pathology Journal Reading
Microscopically Yours: A Glimpse at our Cells, in Sickness and in Health Nina C. Zanetti Siena College Department of Biology.
Procedures used by CHTN
AJCC TNM Staging 7th Edition Breast Case #3
Faculty of Medicine - Benha University
Moving Toward Personalized Treatment for Gastric Cancer: Role of HER2 Testing Frédérique Penault-Llorca, MD, PhD Professor of Pathology Centre Jean Perrin.
Breast Pathology Seminar CASE PRESENTATION PART 1 Elba Torres Matundan MD FCAP Victor Carlo Vargas MD FCAP.
Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
1 Preclinical-Bench Testing II Using Human Observers to Objectively Measure and Evaluate Imaging Performance of Digital WSI Systems Max Robinowitz, MD.
Concept Model for observables, investigations, and observation results For the IHTSDO Observables Project Group and LOINC Coordination Project Revision.
Imaging examinations of breasts
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Pathology Reports Nicole Draper, MD.
First author: Roman Adina Co-author: Andone Sebastian
Pathology.
SNOMED mapping for Pan-Canadian Surgery Templates Elaine Maloney January 27, 2015 ITHSDO Implementation SIG.
W. Scott Campbell, Ph.D., MBA University of Nebraska Medical Center
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Jacob J. Adler.  The following slides are meant for students to navigate on their own or in small groups.  They are expected to have time to research.
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
Draft Observables Concept Model for Deployment of Anatomic/Molecular Pathology.
Oncology in SNOMED CT NCI Workshop The Role of Ontology in Big Cancer Data Session 3: Cancer big data and the Ontology of Disease Bethesda, Maryland May.
Clinical terminology for personalized medicine: Deploying a common concept model for SNOMED CT and LOINC Observables in service of genomic medicine James.
SNOMED CT in Anatomic Pathology
Deploying ONC terminology standards in SNOW SHRINE i2b2 data warehouse
Deploying ONC terminology standards in SNOW SHRINE i2b2 data warehouse
SNOMED CT and Surgical Pathology
Ultrasound breast core needle biopsy
Use cases for molecular pathology/genetics
Indications for Breast MR Imaging
Pancreatic Tumors: Diagnostic Patterns by 3D Gradient-Echo Post Contrast Magnetic Resonance Imaging with Pathologic Correlation  Khaled M. Elsayes, MD,
Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation Reshma Ariga, M.D., Kenneth Bloom, M.D., Vijaya.
Cancer Synoptic Worksheet Encoding Project
Adequacy of Lymph Node Transbronchial Needle Aspirates Using Convex Probe Endobronchial Ultrasound for Multiple Tumor Genotyping Techniques in Non–Small-Cell.
 [P1]Can you put in the numbers here for specificity and NPV
SNOMED CT and Surgical Pathology
SNOMED CT, Synoptic Observables and Clinical Genomics
Patterns of ductal carcinoma in situ (DCIS)
Observable entities and Clinical findings
What is Useful? Publishing Support for Precision Medicine
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Observable entities and Clinical findings
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
SPECIMEN SONOGRAM - Procedure
History 58 year-old female presented with back pain and right toe numbness. Her past medical history was significant for hypertension, glaucoma and.
Predict “invasive component” within ductal carcinoma in situ – the breast MRI features and clinicopathologic factors ? Hung-Wen Lai, MD, PhD1,4, Dar-Ren.
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.
INTERNATIONAL CONFERENCE
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
Handling and Evaluation of Breast Cancer Biopsy
Patient 1. Patient 1. Axial T2 FLAIR (A) MR image demonstrates abnormal T2 FLAIR signal in the right lateral pons extending into the right trigeminal nerve.
Adequacy of Lymph Node Transbronchial Needle Aspirates Using Convex Probe Endobronchial Ultrasound for Multiple Tumor Genotyping Techniques in Non–Small-Cell.
Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors  Geoffrey B. Johnson, MD, PhD, Marie Christine Aubry,
Volume 67, Issue 4, Pages (April 2005)
OF THE EUROPEAN ASSOCIATION OF UROLOGY
Submitted By : Pratish Singh Kuldeep Choudhary Chinmay Panchal
Autopsy MHD
Extending OMOP CDM to Support Observational Cancer Research
H & E = hematoxylin and eosin.
New Provider and Reappointment Training
Presentation transcript:

Histopathology and Proposed Observable entity and evaluation procedure Model W. Scott Campbell, MBA, PhD James R. Campbell, MD University of Nebraska Medical Center

University of Nebraska Medical Center Background Basis of discussion: Recently published investigation of capability of SNOMED CT to represent detailed Histopathology Findings in Breast Biopsies* 24 Biopsy cases reviewed 90+ Unique clinical statements inventoried 75% could be represented using post-coordinated clinical findings and situations with explicit context One (1) statement was fully specified by pre-coordinated concept 25% of statements could not be represented using 2013 international release due to limitations of concept model Pathologists expressed requirement for statement of (un)certainty in pathological findings *Campbell WS, Campbell JR, West WW, McClay JC, Hinrichs SH. Semantic analysis of SNOMED CT for a post-coordinated database of histopathology findings. J Am Med Inform Assoc. 2014.

Expectations of this Discussion University of Nebraska Medical Center Expectations of this Discussion AXIOM: Significant use of post-coordination to represent clinical facts in histopathology is necessary AXIOM: Situation with explicit context hierarchy/model is required for histopathology due to issues of uncertainty Clarification of observables model and application to post-coordinated Situations would benefit from development of templates Goal: Structured and encoded surgical pathology report built directly from structured clinical findings developed with WSA

Surgical Pathology Overview University of Nebraska Medical Center Surgical Pathology Overview Case Clinical Findings Final Pathology Report (Diagnoses) 3 Clinical Findings Specimen 1..n 1 Clinical Findings 2 Blocks Observations 1..n 1 Pathologist Examines Slides by Microscope with various stains Observations lead to Clinical Findings, incorporate other patient information Diagnoses rendered Slides 1 1..n 1

Typical Pathology Report University of Nebraska Medical Center Typical Pathology Report Final Diagnosis: RIGHT BREAST, VACUUM-ASSISTED NEEDLE CORE BIOPSY: - DUCTAL CARCINOMA IN SITU WITH EXTENSIVE PERIDUCTAL SCLEROSIS AND INFLAMMATION. - FOCUS SUSPICIOUS BUT NOT DIAGNOSTIC FOR MICROINVASION. - GROWTH PATTERN: SOLID. - NUCLEAR GRADE: HIGH. - NECROSIS: PRESENT. - MICROCALCIFICATION IN DCIS: YES. Microscopic Report: Performed

Findings to be asserted in final report University of Nebraska Medical Center Findings to be asserted in final report Conclusive statements regarding the patient (person) Example: “Invasive carcinoma of female breast” Clinical Finding reached by aggregation of relevant tissue morphologies and nuclear details observed by the pathologist using microscopy, histopathology and staining techniques Clinical details about the patient: History of breast cancer excised 2010 (Situation) Gross and microscopic observations about the tissue features as evaluated by microscope => Observable entity?

Observable Entities of relevance University of Nebraska Medical Center Observable Entities of relevance Applicable to histopathology microscopic exam Tumor size Presence/absence of particular tissue morphologies Histologic grade? Eosinophil counts How best to represent observation data? |IS ABOUT| some |Clinical finding| |SCALE| some |Scale type| |HAS VALUE| some |value| Concrete domains required for numeric measurements

Situation with Explicit Hierarchy? University of Nebraska Medical Center Situation with Explicit Hierarchy? Surgical Pathology is interpretive Necessary to make assertions of suspicion, probability and negation Example: Ductal carcinoma in situ suspicious for microinvasion The statement is common in clinical practice and VERY important to the patient and subsequent care

University of Nebraska Medical Center Examples

University of Nebraska Medical Center Diagnostic Level Statement: Example: Invasive Carcinoma of female breast 404684003|clinical finding|: {363698007|finding site| = 64633006|lactiferous duct structure|, 116676008|associated morphology| = 82711006|infiltrating duct carcinoma|}, 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| +104157003|light microscopy|)

University of Nebraska Medical Center Diagnostic Level Statement: Example: Ductal Carcinoma in situ suspicious for microinvasion 243796009|situation with explicit context|: {408729009|finding context| = 415684004|suspected|, 410510008|temporal context value| = 410585006|current – unspecified|, 408732007|subject relationship context| = 410604004|subject of record, 246090004|associated finding|= 404684003|clinical finding|: {363698007|finding site| = 64633006|lactiferous duct structure|, 116676008|associated morphology| = 82711006|infiltrating duct carcinoma|} }

University of Nebraska Medical Center Observation of morphology? Epithelial hyperplasia in breast biopsy Not a diagnosis |IS ABOUT| (Property type?) = 404684003|Clinical finding|: {363698007|Finding site|= 31737007|structure of small lactiferous ducts|, 116676008|Associated morphology|= 31390008|epithelial hyperplasia|}, |Scale| = 26716007|qualitative|, |Has value| = 52101004|present|, |Technique| = 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| + 104157003|light microscopy|), |DIRECT SITE|=373102004 | specimen from breast obtained by image guided core biopsy| Ability to call out staining methods important

Observation: Measurement of tumor extent University of Nebraska Medical Center Observation: Measurement of tumor extent |IS ABOUT| = |PROPERTY TYPE| = 444740005|largest dimension of in situ neoplasm|, |INHERES IN| = 86616005|intraductal carcinoma, noninfiltrating|, |Scale| = 30766002|quantitative|, |Has value| = 1.7, |Units| = 258673006|mm|, |Technique| = 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| + 104157003|light microscopy|), |DIRECT SITE|=373102004 | specimen from breast obtained by image guided core biopsy|

Histologic Grade (Option 1) University of Nebraska Medical Center Histologic Grade (Option 1) |IS ABOUT| = 404684003|Clinical finding|: {363698007|Finding site|= 64633006| lactiferous duct structure|, 116676008|Associated morphology|= 86616005|intraductal carcinoma, noninfiltrating, no ICD-O subtype|, 47429007|Associated with|= 373399007|nuclear pleomorphism, grade 2: neither nuclear grade 1 nor nuclear grade 3|}, |Scale| = 26716007|qualitative|, |Has value| = 52101004|present|, |Technique| = 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| + 104157003|light microscopy|) , |DIRECT SITE|=373102004 | specimen from breast obtained by image guided core biopsy|

Histologic Grade (Option 2) University of Nebraska Medical Center Histologic Grade (Option 2) |IS ABOUT| = 404684003|Clinical finding| = 373399007|nuclear pleomorphism, grade 2: neither nuclear grade 1 nor nuclear grade 3|, |INHERES IN| = 86616005|intraductal carcinoma, noninfiltrating|, |Scale| = 26716007|qualitative|, |Has value| = 52101004|present|, |Technique| = 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| + 104157003|light microscopy|) |DIRECT SITE|=373102004 | specimen from breast obtained by image guided core biopsy|

Suspicion as an Observation University of Nebraska Medical Center Suspicion as an Observation |IS ABOUT| = 404684003|Clinical finding|: {363698007|Finding site|= 64633006| lactiferous duct structure|, 116676008|Associated morphology|= 82711006|infiltrating duct carcinoma|}, |Scale| = 26716007|qualitative|, |Has value| = 373068000|undetermined|, |Technique| = 418775008|Finding method|= (104210008|hematoxylin and eosin stain method| + 252416005|histopathology test| + 104157003|light microscopy|) |DIRECT SITE|=373102004 | specimen from breast obtained by image guided core biopsy| 42425007|equivocal| ?

Conclusions: Direction needed University of Nebraska Medical Center Conclusions: Direction needed Clarification of acceptable attribute/value domains and ranges Continue to struggle with descriptive language for architectural features (pre-diagnostic or importance to be determined) Suspicion and probability of the Clinical Finding (diagnostic lines) Binding to synoptic reports

University of Nebraska Medical Center Thank you

University of Nebraska Medical Center